Zacks Investment Research on MSN
NVAX stock falls 8% despite Q3 earnings & sales beat, costs decline
Novavax NVAX recorded a loss of 19 cents per share in the third quarter of 2026, narrower than the Zacks Consensus Estimate ...
Novavax (NASDAQ:NVAX) raised its 2026 revenue framework after partner Sanofi began a late-stage trial of a combination ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results